UnitedHealth Group defied market trends, closing up 1.31% while broader indices faltered slightly. The company’s stock rose ...

Resonant Capital Advisors boosted its Exxon Mobil stake by 7.3% in Q1, adding 3,526 shares to hold 51,869 worth over $6.1M.

Hudson Edge Investment Partners slashed its Johnson & Johnson stake by 18.1% in the first quarter, selling nearly 9,000 ...

Salesforce’s stock had a dramatic year, swinging between $230 and $369 while leaving investors scratching their heads. The ...

Bank of America earned a consensus "Moderate Buy" rating from twenty-six analysts with an average price target of $48.33.

San Francisco’s Union Square has struggled post-pandemic, riddled with store closures, vacancies, and safety concerns despite ...

AbbVie shines as a blue-chip powerhouse, proving stability and growth go hand in hand. The company’s stock climbed 1.26% in a ...

Oracle’s recent financial wins highlight its cloud and AI leadership, but a $2.33M insider sale by its CFO sparked debate.

Merck is gearing up to showcase its promising HIV research at the International AIDS Society Conference in Kigali. This ...

Costco is leveling up its stagflation defense with global expansion and smart tech. The retailer plans to open up to 29 new ...

Advanced Micro Devices will report its Q2 2025 financial results on August 5 after market close, with a webcast conference ...

Capital & Planning LLC reduced its Netflix holdings by 33.4% in Q1, selling 303 shares and retaining 605 worth $564,000.